Cherry Biotech a republié ceci
CEO Cherry Biotech : Better Predict Effects of Drugs on Humans and Replace Animal Experimentation via MultiOmic AI Data Processing from Organ on a Chip Platform
Paris will soon have an entire neighborhood dedicated to the fight against cancer ✊ I was invited last week by Paris Saclay Cancer Cluster (PSCC) for the inauguration of Campus Grand Parc, the largest European cluster dedicated to research on cancer. Right next to Gustave Roussy’s hospital. The event brought together more than 300 innovators in oncology, and marks a key moment in the development of the first oncocluster in France🇫🇷/Europe🇪🇺, which aims to become a key location for innovation in healthcare on the model of the famous Cambridge Innovation Center Kandall Square in Boston🇺🇸. This was an opportunity for us to highlight the role played by organs-on-a-chip and our collaboration with Pierre Savagner from the Gustave Roussy Hospital for breast cancer research. It was a pleasure to share our views with esteemed speakers: Marion Alcantara (Institut Curie), Christian Deleuze (Sanofi), christophe massard (Gustave Roussy), Pr. Eric Vibert, MD, PhD (Hôpital Paul-Brousse, AP-HP, Assistance Publique - Hôpitaux de Paris Congratulations to #PSCC and everyone involved in making this project become a reality. #CampusGrandParc #PSCC #organonchip #3dcellculture #alternativestoanimaltesting #FightAgainstCancer